Editorial. SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes? - Université de Rennes Access content directly
Journal Articles Diabetes & Metabolism Year : 2014

Editorial. SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes?

Dates and versions

hal-01134740 , version 1 (24-03-2015)

Identifiers

Cite

Fabrice Bonnet, André J Scheen. Editorial. SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes?. Diabetes & Metabolism, 2014, 40 (6 Suppl 1), pp.S1-3. ⟨10.1016/S1262-3636(14)72688-6⟩. ⟨hal-01134740⟩
24 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More